Hepatocellular carcinoma: Rising incidence of hepatitis C virus-associated cases at a university clinic in Germany;Hepatozelluläres karzinom: Steigende inzidenz der hepatitis-C-bedingten fälle einer universitätsklinik in Deutschland

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 50, 2002, Pages 2665-2668

  Erhardt, Andreas ^a   Theobald, I ^a   Petry, W ^a   Rohrborn A ^b   Heintges, T ^a   Wettstein, M ^a   Haussinger D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOLISM; ARTICLE; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GERMANY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RATE; INFECTION RISK; LIVER CELL CARCINOMA; MALE; RETROSPECTIVE STUDY; RISK FACTOR; UNIVERSITY HOSPITAL;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037073990     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-36118     Document Type: Article

References (25)

1. Alscher DM, Bode JC. Lebererkrankungen durch alkoholkonsum und hepatitis-c-virusinfektion: Assoziation, addition oder potenzierung? Dtsch Med Wochenschr 2001; 126: 117-122
2. Caselmann WH, Alt M. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J Hepatol 1996; 24: 61-66
3. Caselmann WH, Blum HE, Fleig WE et al. Guidelines of the German Society of Digestive and Metabolic Diseases for diagnosis and therapy of hepatocellular carcinoma. German Society of Digestive and Metabolic Diseases. Z Gastroenterol 1999; 37: 353-65
4. Chang MH, Chen CJ, Lai MS et al. Taiwan Childhood Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 1855-1859
5. El SH, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750
6. Erhardt A, Niederau C, Osman Y, Hassan M, Häussinger D. Nachweis des HFE-polymorphismus bei deutschen patienten mit hereditärer hämochromatose. Dtsch Med Wochenschr 1999; 124: 1448-1452
7. Geissler M, Mohr L, Blum HE. Immuntherapie des hepatozellulären Karzinoms. Dtsch Med Wochenschr 2001; 126: 1464-1466
8. Gerok W, Blum HE. Hepatologie. München: Urban und Schwarzenberg, 1995
9. Hadziyannis SJ, Giannoulis G, Hadziyannis E et al. Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma. J Hepatol 1993; 17: S72-77
10. Hellerbrand C, Hartmann A, Richter G et al. Hepatocellular carcinoma in southern Germany: Epidemiological and clinicopathological characteristics and risk factors. Dig Dis 2001; 19: 345-351
11. Herold C, Reck T, Fischler P et al. Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre. Liver 2002; 22:23-28
12. Kubicka S, Rudolph KL, Hanke M et al. Hepatocellular carcinoma in Germany: A retrospective epidemiological study from a low-endemic area. Liver 2000; 20: 312-318
13. Kubicka S, Rudolph L, Manns MP. Hepatocellular carcinoma: Diagnosis and multi-modality therapy. Internist 1997; 38: 954-962
14. Levrero M, Tagger A, Balsano C et al. Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. J Hepatol 1991; 12: 60-63
15. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699
16. Niederau C, Lange S, Heintges T et al. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study. Hepatology 1998; 28: 1687-1695
17. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Research 1987; 47: 4967-4972
18. Okuda K, Ohtsuki T, Obata H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients. Cancer 1985; 56: 918-928
19. Parkin DM, Stjernsward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 1984; 62: 163-182
20. Petry W, Heintges T, Hensel F et al. Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic. Z Gastroenterol 1997; 35: 1059-1067
21. Poynard T, Bedossa P, Opolon P The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832
22. Rabe C, Pilz T, Klostermann C et al. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001; 7: 208-215
23. Sarasin FP, Giostra E, Mentha G, Hadengue A. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 1998; 28: 436-442
24. Trevisani F, D'Intino PE, Caraceni P et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer 1995; 75: 2220-2232
25. Wettstein M, Erhardt A, Petry W, Niederau C, Häussinger D. Hepatozelluläres karzinom bei hepatitis-c-infektion. Berlin-Wien: Blackwell, In Häussinger D, Niederau C, eds. Hepatitis C. 2001: 187-223